Thursday, September 18, 2008 – Washington, DC
7:00 - 10:00 p.m. Welcome Reception and Dinner

Day 1 – Friday, September 19, 2008

(Download Full Agenda as PDF)Day 2 Agenda

7:00–8:00

Registration and Breakfast

8:00–8:05

INTRODUCTORY COMMENTS

Francine M. Foss, MD, Cochair

8:05-8:10

INTRODUCTION OF KEYNOTE SPEAKER

Pier Luigi Zinzani, MD, PhD, Cochair

8:10-8:55

KEYNOTE SPEAKER

Bertrand Coiffier, MD

EPIDEMIOLOGY AND PATHOBIOLOGY OF T-CELL LYMPHOMAS
Moderators: Elaine S. Jaffe, MD; Randy D. Gascoyne, MD
8:55-9:10 Classification of T-cell NHL

Elaine S. Jaffe, MD
9:10-9:25 Epidemiology and Outcomes for T-cell Lymphoma from the International T-cell Lymphoma Study Julie M. Vose, MD
9:25-9:40 Epidemiology of PTCL

Sophia S. Wang, PhD
9:40-9:55 Prognostic Groups Kerry J. Savage, MD
9:55-10:10 What We Have Learned - New Classification Strategies

Dennis D. Weisenburger, MD
10:10-10:25 Discussion to the Epidemiology and
Pathobiology of T-Cell Lymphomas
10:25-10:40 Break

GENE EXPRESSION ANALYSIS
Moderators: Miguel A. Piris, MD, PhD; Dennis D. Weisenburger, MD
10:40-10:55 Gene Profiling Data from the International T-cell Lymphoma Project

Wing Chung (John) Chan, MD
10:55-11:10 Gene Expression Analysis in PTCL Miguel A. Piris, MD, PhD
11:10-11:25 Functional Profiling of the T-cell Receptor
Pathway in PTCL

Dan M. Jones, MD, PhD

11:25-11:40 How Can Gene Array Data Improve Prognosis? Randy D. Gascoyne, MD
11:40-12:00 Discussion
12:00-1:00 Lunch

MOLECULAR MECHANISMS
Moderators: Pierluigi Porcu, MD; Dan M. Jones, MD, PhD
1:00-1:15 NF-kB and T-cell NHL

Arnold B. Rabson, MD
1:15-1:30 The Molecular Biology of
Angioimmunoblastic T-cell Lymphoma

Philippe Gaulard, MD
1:30-1:45 HTLV-1 Associated Lymphomas

Thomas A. Waldmann, MD
1:45-2:00 T-cell Prolymphocytic Leukemias

Claire E. Dearden, MD
2:00-2:15 Discussion

2:15-2:30 Break

THERAPEUTIC APPROACHES
Moderators: Steven M. Horwitz, MD; Julie M. Vose, MD
2:30-2:45 First-line Therapy for PTCL

Christian Gisselbrecht, MD
2:45-3:00 Use of Campath, EPOCH in PTCL

Wyndham H. Wilson, MD, PhD
3:00-3:15 New Approaches to First-line Therapy: Ontak, SGN35+CHOP, Pentostatin, and Others

Francine M. Foss, MD
3:15-3:30 NK Lymphomas - Biology and Treatment

John P. Greer, MD
3:30-3:45 Japanese Experience in the Treatment of PTCL

Kensei Tobinai, MD, PhD
3:45-4:00 Discussion

TRANSPLANTATION
Moderators: Steven T. Rosen, MD; Francine M. Foss, MD
4:00-4:15 Allo-transplantation for T-cell Lymphomas

Jose Rodriguez, MD, PhD
4:15-4:30 Is There a Role for Auto-transplantation
in T-cell Lymphoma? Part I

Francesco d’Amore, MD, DMSc
4:30-4:45 Is There a Role for Auto-transplantation
in T-cell Lymphoma? Part II

Peter Reimer, MD
4:45-5:00 Review of IBMTR Data for T-cell Lymphoma

Francine M. Foss, MD
5:00-5:15 Discussion

(Download Full Agenda as PDF)Back to Top